Search SciPol

Brought to you by
June 16, 2017 12:30 pm - June 16, 2017 2:30 pm

Meeting: Office of National Drug Control Policy, President's Commission on Combating Drug Addiction and the Opioid Crisis

  • Government
  • Executive
  • Neuroscience

The Office of National Drug Control Policy (ONDCP), within the Executive Office of the President, announces the first meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis to advance the Commission's work on drug issues and the opioid crisis per Executive Order 13784. The first meeting will consist of statements to the Commission from invited nonprofit organizations regarding drug issues followed by discussion of the issues raised.

The Commission will function solely as an advisory body and will make recommendations regarding policies and practices for combating drug addiction with particular focus on the current opioid crisis in the United States. The Commission's final report is due October 1, 2017 unless there is an Start Printed Page 24996extension. Per E.O. 13784, the Commission shall:

  1. Identify and describe the existing Federal funding used to combat drug addiction and the opioid crisis;
  2. Assess the availability and accessibility of drug addiction treatment services and overdose reversal throughout the country and identify areas that are underserved;
  3. Identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, collaboration between State and Federal officials, and the use and effectiveness of State prescription drug monitoring programs;
  4. Review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids;
  5. Identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and effectiveness, and make recommendations for improving these programs; and;
  6. Make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis.

Members of the public can attend the meeting via an online livestream. More information is available via the Federal Register notice.